![]() |
Hepatitis |
Free Subscription
1 Ann Intern Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
Guideline recommends antiviral prophylaxis for patients at high risk for HBV
reactivation.
Ann Intern Med. 2025;178:JC50.
PubMed
Abstract available
Uptake of combined immunoprophylaxis for newborns exposed to hepatitis B virus in
a high hepatitis B endemic rural setting in Northern Ghana.
BMC Pediatr. 2025;25:407.
PubMed
Abstract available
Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C
Among US Adults.
Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093.
PubMed
Abstract available
Screening and vaccination rates for tetanus, hepatitis A, and hepatitis B among
individuals with substance use disorders who are hospitalized in an integrated
U.S. health system.
Clin Infect Dis. 2025 May 20:ciaf251. doi: 10.1093.
PubMed
Abstract available
Management of Immune Tolerant Chronic Hepatitis B.
Hepatology. 2025 May 20. doi: 10.1097/HEP.0000000000001407.
PubMed
Abstract available
Retraction: C-Jun mediates hepatitis C virus hepatocarcinogenesis through signal
transducer and activator of transcription 3 and nitric oxide-dependent impairment
of oxidative DNA repair.
Hepatology. 2025;81:E181.
PubMed
Infliximab to the rescue: Autoimmune hepatitis meets its match.
Hepatology. 2025;81:1621-1622.
PubMed
Disparity landscapes of viral-induced structural variations in hepatocellular
carcinoma: Mechanistic characterization and functional implications.
Hepatology. 2024 Sep 13. doi: 10.1097/HEP.0000000000001087.
PubMed
Abstract available
Cellular interactions in self-directed immune-mediated liver diseases.
J Hepatol. 2025;82:1110-1124.
PubMed
Abstract available
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks
in patients with HDV-related cirrhosis.
J Hepatol. 2025 Jan 8:S0168-8278(25)00001-7. doi: 10.1016/j.jhep.2024.
PubMed
Abstract available
Reduction of Bacteroides fragilis in Gut Microbiome of Chronic Hepatitis B
Patients Promotes Liver Injury.
J Med Virol. 2025;97:e70395.
PubMed
Abstract available
Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions
in the HBeAg-Negative Stage of Chronic Hepatitis B.
J Med Virol. 2025;97:e70398.
PubMed
Abstract available
Environmental Surveillance of Hepatitis E Virus and Rat Hepatitis E Virus in
Portugal and Spain, 2020-2022.
J Med Virol. 2025;97:e70414.
PubMed
Abstract available
DNAJC9 Binds to and Enhances the Transcription of Hepatitis B Virus cccDNA by
Recruiting Histone H3.3.
J Med Virol. 2025;97:e70390.
PubMed
Abstract available
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good
Option! The DEVICHO Study.
J Viral Hepat. 2025;32:e70038.
PubMed
Abstract available
Utilizing Theory of Planned Behaviour to increase intention to participate in
hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT)
in Malaysia: A cluster randomised control trial.
PLoS One. 2025;20:e0324718.
PubMed
Abstract available
Evaluating the effectiveness of a population-level health intervention to
increment HCV treatment coverage in tuscany region, Italy: An interrupted time
series analysis.
PLoS One. 2025;20:e0306733.
PubMed
Abstract available
Seroprevalence of hepatitis A virus infection in urban and rural areas in
Vietnam.
PLoS One. 2025;20:e0323139.
PubMed
Abstract available
Antigenic and EM characterization of the Chiron experimental hepatitis C virus
vaccine.
Vaccine. 2025;58:127239.
PubMed
Abstract available
Overrange dilution for improvement of hepatitis B core related antigen as a
biomarker: protocol validation and examples for application.
Virology. 2025;609:110576.
PubMed
Abstract available
Thank you for your interest in scientific medicine.